Longevity9 min read·Published November 17, 2026

Longevity vs Healthspan: What Is the Difference?

How researchers measure healthy aging, what human studies can show, and where the evidence still stops.

Longevity vs Healthspan: What Is the Difference?

Longevity is the length of life, while healthspan is the part of life spent with good function and independence. Healthspan is a more practical near-term research goal because human studies can measure function, frailty, safety, and quality of life, but they rarely can prove that an intervention extends human lifespan.

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

What is the difference between longevity, lifespan, and healthspan?

Longevity is a broad term about how long people live. Across a lifetime, it can refer to an individual, a population, or the biology of aging. The World Health Organization describes healthy aging as maintaining functional ability that supports well-being in older age 7.

Longevity: a broad term about length of life

Longevity is often used in conversations about aging research, prevention, and health habits. It does not mean that a person will reach a specific age, and it does not prove that a treatment changes human lifespan.

Lifespan: the total number of years lived

Lifespan is the total length of one person’s life. Population life expectancy is different: it is a statistical estimate of average years remaining at a given age, based on death rates in a population.

Healthspan: years lived with preserved function

Healthspan describes years in which you can move, think, manage daily life, and stay connected to what matters to you. It is not one universally standardized score. Researchers combine several measures because aging affects physical, mental, and social function 7.

TermPlain-language meaningHow it is commonly studied
LongevityA broad idea about length of lifePopulation survival patterns and aging biology
LifespanThe total years one person livesAge at death or survival over time
Life expectancyAverage remaining years for a populationPopulation mortality data
HealthspanYears lived with function and less disabilityMobility, frailty, cognition, disease burden, and quality of life

Why do healthy-aging researchers focus on healthspan?

Healthspan matters because daily function and independence are outcomes people can feel and researchers can measure. Over months or years, trials can track walking ability, strength, frailty, symptoms, and safety more directly than lifespan.

A lifespan trial would need to follow large groups for decades. It would also need to separate a study intervention from differences in income, health care, habits, environment, and medical conditions. That makes direct lifespan proof unusually difficult.

Function, independence, and frailty are patient-relevant outcomes

Frailty is a state of lower reserve that can make a person more vulnerable to falls, illness, hospitalization, and loss of independence. A 2026 phase 2b randomized trial evaluated laromestrocel for aging frailty, showing how trials can focus on a functional aging outcome rather than lifespan itself 2.

A lab marker is not the same as a clinical benefit

Biomarkers of aging are measurements from blood, cells, imaging, or physical testing that may help researchers study aging. A changed biomarker can be useful, but it does not by itself show that a person will live longer, avoid disability, or feel better in daily life 4 5.

This distinction matters for supplements, peptides, diets, and medicines. A human randomized trial can show a short-term change in a marker or function measure, yet still leave long-term benefits and harms uncertain 1 4.

How is healthspan measured in human research?

Healthspan measurement uses several outcomes because aging affects more than one body system. One test alone cannot capture mobility, thinking, resilience, disease burden, and quality of life 7.

Physical function, mobility, strength, and daily activity

Studies may assess walking, balance, grip strength, exercise capacity, falls, or activities of daily living. The CALERIE phase 2 analysis examined physical-activity energy expenditure and markers of healthspan during prolonged calorie restriction in people without obesity 6.

Frailty and multimorbidity

Researchers may measure frailty and multimorbidity, meaning two or more long-term health conditions. These measures can reflect real-world vulnerability, but they can change for reasons unrelated to a single treatment 2 7.

Cognitive, immune, and quality-of-life measures

Memory tests, mood measures, vaccine responses, and quality-of-life questionnaires can add useful context. A 2026 pilot randomized study of spermidine in healthy older adults assessed immune-cell senescence and vaccine-response outcomes, not lifespan 5.

Biomarkers: useful tools with important limits

Blood markers and cell-based measures can help test a biological idea early. They should not be treated as proof that aging has been reversed or that a therapy extends human life 4 5.

What does human longevity research actually show?

Human longevity research can test safety and near-term healthspan measures, but it has not established a treatment that extends human lifespan. After one year, the PEARL randomized trial evaluated rapamycin safety and healthspan metrics; that time frame cannot answer whether participants lived longer 4.

Human randomized clinical trials

Human randomized clinical trials compare groups by chance assignment, which helps reduce bias. A 2023 randomized, double-blind trial studied NMN supplementation in healthy middle-aged adults for efficacy and safety outcomes, but its design did not establish longer human lifespan 1.

Potential benefits in early aging trials must be weighed against side effects, interactions, and unknown long-term risks. For example, a finding in a short trial does not establish safety for years of use or for people with complex medical histories.

Human observational research

Human observational research follows what people already do or experience. It can identify associations between activity, diet, social factors, and health outcomes, but it cannot reliably prove that one factor caused the outcome because groups differ in many ways.

Animal and cell research

Animal research can test mechanisms and lifespan in a much shorter time than human research. Cell research can show what happens in isolated cells. Both are important early steps, but neither proves a treatment improves healthspan or lifespan in people.

The 2015 fasting-mimicking diet study included both human and preclinical work. Its findings need to be separated by evidence type; preclinical regeneration or healthspan findings are not proof of longer human life 3.

  • Human randomized evidence: strongest for short-term cause-and-effect questions, but often too short for lifespan.
  • Human observational evidence: useful for patterns, but associations can reflect other factors.
  • Animal evidence: useful for biology and early testing, but may not translate to people.
  • Cell evidence: useful for mechanisms, but cannot predict whole-body human outcomes.

Can lifestyle changes support a longer healthspan?

Evidence-based prevention is the most established path for supporting function as you age. Each week, physical activity, sleep, nutrition, preventive care, and social connection can support health, though none guarantees a longer life.

The U.S. physical activity guidelines recommend regular movement that fits a person’s abilities and health status. Activity can improve physical function and lower chronic-disease risk, but people with symptoms or health conditions may need individualized guidance 8.

Chronic-disease care also matters. Managing blood pressure, diabetes, depression, pain, hearing, vision, and medication side effects can help support day-to-day function 7. Our guide to an evidence-based healthy aging strategy covers these practical foundations in more detail.

How does Chia approach longevity-focused care?

Chia’s longevity-focused care starts with a licensed provider’s review, not a promise of longer life. 100% online, patients complete a health questionnaire, and a licensed U.S. provider decides whether any treatment is clinically appropriate.

Our Foundation Longevity protocol includes compounded Sermorelin Injection, NAD+ Injection, and Glutathione Injection, which are not FDA-approved. Plans currently start at $399 per month. The protocol is not established to extend healthspan or lifespan, and each component has its own evidence limits, risks, and suitability considerations.

What Foundation Longevity includesHow Chia delivers careWhat the evidence does not show
Sermorelin Injection, NAD+ Injection, and Glutathione InjectionProvider review, provider-guided dosing, patient-portal messaging, and home deliveryThat the protocol extends human lifespan or reverses aging
Compounded medications from state-licensed U.S. 503A pharmaciesTreatment is prescribed only when clinically appropriateFDA-evaluated outcomes data for the compounded protocol

We encourage patients to ask what has been studied in humans, what outcomes were measured, and what remains unknown. For more context, see our guides to what human longevity research shows, peptides for longevity, and the difference between longevity and length of life.

3-min quiz

Explore longevity goals with a licensed provider

You can complete Chia’s online health questionnaire for a licensed U.S. provider to review your goals and health history. A prescription is not guaranteed. Our medications are compounded by state-licensed 503A pharmacies and are not FDA-approved; read about the Foundation Longevity protocol before your visit.

What should you ask before pursuing a longevity treatment or program?

The best questions focus on human outcomes, safety, and the quality of the evidence. Before starting, ask whether the goal is better function, symptom support, a lab-marker change, or something else.

  1. 1What outcome was studied in people: function, frailty, symptoms, a biomarker, or lifespan?
  2. 2Was the evidence from a randomized human trial, observational research, animals, or cells?
  3. 3How long did the study last, and who was included?
  4. 4What side effects, medication interactions, and long-term unknowns apply?
  5. 5Is a licensed clinician reviewing whether the approach fits your health history and current medications?

Be especially careful with claims that a product “reverses aging” or “extends lifespan.” Those claims require long-term human evidence, not only a changed lab value, animal result, or personal story 1 4.

Frequently asked questions about longevity and healthspan

3-min quiz

Start with an online clinical review

If you want to discuss longevity-focused goals, complete an online health questionnaire for review by a licensed U.S. provider. A prescription is not guaranteed. Any medications dispensed through Chia are compounded by state-licensed 503A pharmacies and are not FDA-approved.

References

  1. 1.Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023.
  2. 2.Ruiz JG, Oliva AA Jr, Ramdas KN, et al. Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty. Cell Stem Cell. 2026.
  3. 3.Brandhorst S, Choi IY, Wei M, et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metabolism. 2015.
  4. 4.Moel M, Harinath G, Lee V, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging. 2025.
  5. 5.Alsaleh G, Ali M, Kayvanjoo AH, et al. Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults—A Pilot Study. Aging Cell. 2026.
  6. 6.Dorling JL, Martin CK, Das SK, et al. Association between physical activity energy expenditure and markers of healthspan during prolonged calorie restriction in individuals without obesity: observations from the CALERIE phase 2 randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity. 2025.
  7. 7.World Health Organization. Decade of Healthy Ageing: Baseline Report. 2020.
  8. 8.U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. 2018.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides